Mechanisms involved in the induced differentiation of leukemia cells

被引:137
作者
Tsiftsoglou, AS [1 ]
Pappas, IS [1 ]
Vizirianakis, IS [1 ]
机构
[1] Aristotle Univ Thessaloniki, Dept Pharmaceut Sci, Pharmacol Lab, GR-54124 Thessaloniki, Greece
关键词
leukemia; differentiation; apoptosis; hematopoietic cells; mechanisms; chemical inducers;
D O I
10.1016/j.pharmthera.2003.09.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Despite the remarkable progress achieved in the treatment of leukemias over the last several years, many problems (multidrug resistance [MDR], cellular heterogeneity, heterogeneous molecular abnormalities, karyotypic instability, and lack of selective action of antineoplastic agents) still remain. The recent progress in tumor molecular biology has revealed that leukemias are likely to arise from disruption of differentiation of early hematopoietic progenitors that fail to give birth to cell lineage restricted phenotypes. Evidence supporting such mechanisms has been derived from studying bone marrow leukemiogenesis and analyzing differentiation of leukemic cell lines in culture that serve as models of erythroleukemic (murine erythroleukemia [MEL] and human leukemia [K562] cells) and myeloid (human promyelocytic leukemia [HL-60] cells) cell maturation. This paper reviews the current concepts of differentiation, the chemical/pharmacological inducing agents developed thus far, and the mechanisms involved in initiation of leukemic cell differentiation. Emphasis was given on commitment and the cell lineage transcriptional factors as key regulators of terminal differentiation as well as on membrane-mediated events and signaling pathways involved in hematopoietic cell differentiation. The developmental program of MEL cells was presented in considerable depth. It is quite remarkable that the erythrocytic maturation of these cells is orchestrated into specific subprograms and gene expression patterns, suggesting that leukemic cell differentiation represents a highly coordinated set of events that lead to irreversible growth arrest and expression of cell lineage restricted phenotypes. In MEL and other leukemic cells, differentiation appears to be accompanied by differentiation-dependent apoptosis (DDA), an event that can be exploited chemotherapeutically. The mechanisms by which the chemical inducers promote differentiation of leukemic cells have been discussed. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:257 / 290
页数:34
相关论文
共 402 条
[1]   DIFFERENTIATION OF MOUSE MYELOID-LEUKEMIA CELLS INDUCED BY 1-ALPHA,25-DIHYDROXYVITAMIN-D3 [J].
ABE, E ;
MIYAURA, C ;
SAKAGAMI, H ;
TAKEDA, M ;
KONNO, K ;
YAMAZAKI, T ;
YOSHIKI, S ;
SUDA, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (08) :4990-4994
[2]   SYNTHETIC ANALOGS OF VITAMIN-D3 WITH AN OXYGEN ATOM IN THE SIDE-CHAIN SKELETON - A TRAIL OF THE DEVELOPMENT OF VITAMIN-D COMPOUNDS WHICH EXHIBIT POTENT DIFFERENTIATION-INDUCING ACTIVITY WITHOUT INDUCING HYPERCALCEMIA [J].
ABE, J ;
MORIKAWA, M ;
MIYAMOTO, K ;
KAIHO, SI ;
FUKUSHIMA, M ;
MIYAURA, C ;
ABE, E ;
SUDA, T ;
NISHII, Y .
FEBS LETTERS, 1987, 226 (01) :58-62
[3]   A SYNTHETIC ANALOG OF VITAMIN-D3, 22-OXA-1-ALPHA,25-DIHYDROXYVITAMIN-D3, IS A POTENT MODULATOR OF INVIVO IMMUNOREGULATING ACTIVITY WITHOUT INDUCING HYPERCALCEMIA IN MICE [J].
ABE, J ;
TAKITA, Y ;
NAKANO, T ;
MIYAURA, C ;
SUDA, T ;
NISHII, Y .
ENDOCRINOLOGY, 1989, 124 (05) :2645-2647
[4]   ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain [J].
Amann, JM ;
Nip, J ;
Strom, DK ;
Lutterbach, B ;
Harada, H ;
Lenny, N ;
Downing, JR ;
Meyers, S ;
Hiebert, SW .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (19) :6470-6483
[5]   Function of the c-Myc oncoprotein in chromatin remodeling and transcription [J].
Amati, B ;
Frank, SR ;
Donjerkovic, D ;
Taubert, S .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2001, 1471 (03) :M135-M145
[6]   Histone deacetylase inhibitors induce caspase-dependent apoptosis and downregulation of daxx in acute promyelocytic leukaemia with t(15;17) [J].
Amin, HM ;
Saeed, S ;
Alkan, S .
BRITISH JOURNAL OF HAEMATOLOGY, 2001, 115 (02) :287-297
[7]   Altered expression and activity of topoisomerases during all-trans retinoic acid-induced differentiation of HL-60 cells [J].
Aoyama, M ;
Grabowski, DR ;
Isaacs, RJ ;
Krivacic, KA ;
Rybicki, LA ;
Bukowski, RM ;
Ganapathi, MK ;
Hickson, ID ;
Ganapathi, R .
BLOOD, 1998, 92 (08) :2863-2870
[8]   POLAR APOLAR COMPOUNDS INDUCE LEUKEMIA-CELL DIFFERENTIATION BY MODULATING CELL-SURFACE POTENTIAL [J].
ARCANGELI, A ;
CARLA, M ;
DELBENE, MR ;
BECCHETTI, A ;
WANKE, E ;
OLIVOTTO, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (12) :5858-5862
[9]   p21WAF1 is required for butyrate-mediated growth inhibition of human colon cancer cells [J].
Archer, SY ;
Meng, SF ;
Shei, A ;
Hodin, RA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (12) :6791-6796
[10]   Activation of erythroid-specific promoters during anthracycline-induced differentiation of K562 cells [J].
Aries, A ;
Trentesaux, C ;
Ottolenghi, S ;
Jardillier, JC ;
Jeannesson, P ;
Doubeikovski, A .
BLOOD, 1996, 87 (07) :2885-2890